Cycle 3 2015 New Oral Anticoagulants (NOACs) in the Extended Treatment of Venous Thromboembolic Disease LOI Town Hall

This town hall provided an overview of PCORI and help ensure that applicants submitting to the New Oral Anticoagulants (NOACs) in the Extended Treatment of Venous Thromboembolic Disease - Cycle 3 2015 PFA have the information they need to submit a responsive letter of intent (LOI).

Speakers

• Diane E. Bild, MD, MPH, Senior Program Officer
  Assessment of Prevention, Diagnosis, and Treatment Options (Clinical Effectiveness Research) program
• Allison Ambrosio, MPH, Program Associate
  Assessment of Prevention, Diagnosis, and Treatment Options (Clinical Effectiveness Research) program
• Suzanne Schrandt, JD, Deputy Director
  Patient Engagement
• Maricon Gardner, CRA, Contracts Associate, Pre-Award
  Contracts Management and Administration

Meeting Materials

• Presentation Slides